glp 1 analogue moa Mechanism of action of GLP-1 agonists – My Endo Consult Structure-Based Discovery of Orthosteric Non-Peptide

They are not sold for clinical, therapeutic, or personal use.

What body areas can be treated

10.1038/nm.3766 32

N., & Zhmurenko, L

Organic Chemistry(0) Introduction to Organic Chemistry(0) Structural Formula(0) Condensed Formula(0) Skeletal Formula(0) Spatial Orientation of Bonds(0) Intro to Hydrocarbons(0) Isomers(0) Chirality(0) Functional Groups in Chemistry(0) Naming Alkanes(0) The Alkyl Groups(0) Naming Alkanes with Substituents(0) Naming Cyclic Alkanes(0) Naming Other Substituents(0) Naming Alcohols(0) Naming Alkenes(0) Naming Alkynes(0) Naming Ketones(0) Naming Aldehydes(0) Naming Carboxylic Acids(0) Naming Esters(0) Naming Ethers(0) Naming Amines(0) Naming Benzene(0) Alkane Reactions(0) Intro to Addition Reactions(0) Halogenation Reactions(0) Hydrogenation Reactions(0) Hydrohalogenation Reactions(0) Alcohol Reactions: Substitution Reactions(0) Alcohol Reactions: Dehydration Reactions(0) Intro to Redox Reactions(0) Alcohol Reactions: Oxidation Reactions(0) Aldehydes and Ketones Reactions(0) Ester Reactions: Esterification(0) Ester Reactions: Saponification(0) Carboxylic Acid Reactions(0) Amine Reactions(0) Amide Formation(0) Benzene Reactions(0) 23

Nonalcoholic fatty liver disease has become one of the hepatic diseases of greatest interest recently due to its epidemiological impact, with impressive clinical and physiopathologic advances and more profound knowledge about its mechanisms that lead to persistent fibrosis, which is intimately related with NRF-2